CONCERTO II. CONSULTA, MAXIMO II, PROTECTA, PROTECTA XT
FDA premarket approval P010031/S268 · decided 2012-07-23
Approval details
- PMA number
- P010031
- Supplement
- S268
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONCERTO II. CONSULTA, MAXIMO II, PROTECTA, PROTECTA XT
- Generic name
- Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2011-07-18
- Decision date
- 2012-07-23
- Days to decision
- 371 days
- Decision code
- APPR
- Product code
- NIK
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- APPROVAL FOR A CHANGE TO THE BURN-IN TESTING PROCESS FOR TANTALUM CAPACITORS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.